3.8 Article

Major depression and disease activity among systemic lupus erythematosus Egyptian females

Journal

EGYPTIAN RHEUMATOLOGIST
Volume 37, Issue 4, Pages S1-S6

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejr.2015.09.007

Keywords

Systemic lupus erythematosus; Major depression; SLEDAI; SLICC/ACR DI

Categories

Ask authors/readers for more resources

Aim of the work: The aim of this study was to identify the relationship between disease activity in SLE Egyptian females and the presence, severity and pattern of major depression in these patients. Patients and methods: The study sample included 100 female patients; fifty SLE patients and fifty healthy adults with matching age serving as control. Patients were assessed using Beck Inventory Score for the presence of major depression, SLEDAI to determine disease activity, SLICC/ACR damage index and HAQ score for functional disability. Results: The majority of patients had symptoms of major depression 32/50 (64%) based on Beck Inventory Score while in controls only 16/50 (36%) had major depression. The most common depressive symptoms in SLE patients were: Guilty feeling (92%), Self-dislike (91.6%), Selfcriticalness (90.4%), Crying spells (87.5%), Loss of pleasure (83.3%), Change in appetite (83.3%), Agitation (82.8%) and Pessimism (82%). Patients with major depression presented a trend toward having greater severity of SLE disease activity compared with those without major depression (p =0.04). The presence of major depression was significantly associated with functional disability measured by HAQ score (p=0.01). The patients with major depression did not differ significantly from patients without major depression regarding their steroid dosage (p=0.55), SLICC/ACR damage score (p=0.16) and disease duration (p =0.69) but differed significantly as regards Beck Hopelessness Scale (p<0.0001) and suicidal ideation score (p=0.009). Conclusion: Major depression was highly presented in Egyptian SLE patients (64%); its severity was associated with disease activity, but not with steroid administration, cumulative damage or disease duration. (C) 2015 The Authors. Production and hosting by Elsevier B. V. on behalf of Egyptian Society of Rheumatic Diseases. This is an open access article under the CC BY-NC-ND license.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available